Stephen W. Kaldor

Stephen W.
Kaldor is the founder of Fount Therapeutics LLC, serving as Chief Executive Officer & Director since 2016.
Dr. Kaldor was the founder of Kinnate Biopharma, Inc., serving as Director from 2020 to 2021.
Dr. Kaldor was the founder of XinThera, Inc., serving as Chairman.
Current job includes Director at Resolute Therapeutics, Inc. since 2016.
Former jobs include President & Chief Executive Officer at Ambrx, Inc. from 2007 to 2010, President, Chief Executive Officer & Director at Quanticel Pharmaceuticals, Inc. from 2011 to 2015, Director at Amira Pharmaceuticals, Inc. from 2008 to 2011, Independent Director at Furiex Pharmaceuticals, Inc. from 2012 to 2014, Director at Bird Rock Bio Sub, Inc., Independent Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2021, Principal at Eli Lilly & Co. from 1989 to 2001, President & Chief Scientific Officer at Syrrx, Inc. in 2005, Venture Partner at Versant Venture Management LLC, and President & Chief Scientific Officer at Takeda San Diego, Inc. from 2005 to 2007.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from Harvard University, conferred in 1989.